The HNF4G-KO resulted in slower tumor growth compared to control (Cas9) tumors (P < 0.0001) and substantially smaller tumors (Fig. 2f), confirming that HNF4G is required for optimal tumor growth. This evidence concerns the gene HNF4G and neoplasm.